½ÃÀ庸°í¼­
»óǰÄÚµå
1672641

Ç×±ÕÁ¦ °¨¼ö¼º ½ÃÇè ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ¹æ¹ýº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°

Antimicrobial Susceptibility Testing Market, By Product Type, By Application, By Method, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Ç×±ÕÁ¦ °¨¼ö¼º ½ÃÇè ½ÃÀåÀº 2025³â¿¡ 42¾ï 1,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2032³â¿¡´Â 67¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â ¿¬°£ Æò±Õ ¼ºÀå·ü(CAGR)Àº 6.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ »ó¼¼ ³»¿ë
±âÁØ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 42¾ï 1,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£: 2025-2032³â CAGR: 6.90% 2032³â °¡Ä¡ ¿¹Ãø 67¾ï 2,000¸¸ ´Þ·¯
µµÇ¥. 2025³â Áö¿ªº° Ç×±ÕÁ¦ °¨¼ö¼º Å×½ºÆ® ½ÃÀå Á¡À¯À²(%)
Antimicrobial Susceptibility Testing Market-IMG1

¼¼°è Ç×±ÕÁ¦ °¨¼ö¼º Å×½ºÆ® ½ÃÀåÀº 2025-2032³â Å« ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ÁÖ·Î Àü ¼¼°è¿¡¼­ °¨¿°¼º Áúȯ Áõ°¡¿Í ÀûÀýÇÑ Ç×±ÕÁ¦ Ä¡·á¹ýÀ» ½Äº°ÇÒ Çʿ伺ÀÌ ³ô¾ÆÁ³±â ¶§¹®ÀÔ´Ï´Ù. ÃÖ±Ù ¿¬±¸¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â ¸Å³â ÃÖ¼Ò 200¸¸ ¸íÀÌ Ç×»ýÁ¦ ³»¼º °¨¿°À¸·Î ÀÎÇØ ÃÖ¼Ò 23,000¸í ÀÌ»óÀÌ »ç¸ÁÇÏ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ÀÓ»óÀǰ¡ ÀûÀýÇÑ Ä¡·á¹ýÀ» ¼±ÅÃÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â Ç×»ýÁ¦ °¨¼ö¼º¿¡ ´ëÇÑ Áß¿äÇÑ Á¤º¸¸¦ Á¦°øÇÏ´Â È¿°úÀûÀÎ Ç×±ÕÁ¦ °¨¼ö¼º °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÚµ¿È­ ¹× ÀΰøÁö´ÉÀÇ ÅëÇÕ°ú °°Àº °¨¼ö¼º °Ë»ç ±â¼úÀÇ ±â¼úÀû ¹ßÀüÀ¸·Î ÀÎÇØ ÇÁ·Î¼¼½º°¡ ´õ ºü¸£°í ½¬¿öÁ® ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°è Ç×±ÕÁ¦ °¨¼ö¼º °Ë»ç ½ÃÀåÀº ÁÖ·Î Ç×»ýÁ¦ ³»¼º ¹Ì»ý¹° °¨¿° Áõ°¡¿Í °¡Àå È¿°úÀûÀÎ Ç×±ÕÁ¦¸¦ °áÁ¤Çϱâ À§ÇÑ ½Å¼ÓÇϰí Á¤È®ÇÑ Ç×±ÕÁ¦ °¨¼ö¼º °Ë»ç¹ýÀÇ Çʿ伺¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î´Â º´¿ø³» °¨¿° Áõ°¡, Çâ»óµÈ ±â´ÉÀ» °®Ãá ½ÅÁ¦Ç° Ãâ½Ã Áõ°¡, Ç×±ÕÁ¦ ½ºÆ©¾îµå½Ê ½ÇõÀ» ÃËÁøÇϱâ À§ÇÑ Á¤ºÎ ¹× º¸°Ç ±â°üÀÇ ³ë·Â µîÀÌ ÀÖ½À´Ï´Ù. ±×·¯³ª »õ·Î¿î AST ½Ã½ºÅÛÀÇ ½ÂÀÎ ÀýÂ÷¿¡ ½Ã°£ÀÌ ¿À·¡ °É¸®´Â Á¡, ¿ÏÀü ÀÚµ¿È­ ½Ã½ºÅÛ°ú °ü·ÃµÈ ³ôÀº ºñ¿ë, ¼öµ¿ °Ë»ç¹ý°ú °ü·ÃµÈ ºÎÁ¤È®¼º µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ½ÃÀå ¼ºÀåÀÌ ÀúÇØµÉ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå °³¹ßÀÇ ÁÖ¿ä ±âȸ·Î´Â ³ôÀº 󸮷® ±â´ÉÀ» °®Ãá ½Å¼ÓÇÑ AST Ç÷§ÆûÀÇ °³¹ß, ½ÅÈï ±¹°¡¿¡¼­ÀÇ Ã¤Åà Ȯ´ë, ºÐÀÚÁø´Ü ±â¼ú°ú ASTÀÇ ÅëÇÕ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ¼¼°èÀÇ Ç×±ÕÁ¦ °¨¼ö¼º Å×½ºÆ® ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR%)À» °ÔÀçÇϰí ÀÖ½À´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¸ÅÃâ ¼ºÀå ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ¼¼°è Ç×±ÕÁ¦ °¨¼ö¼º Å×½ºÆ® ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ±â¾÷ °³¿ä, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä Æ¯Â¡, ½ÇÀû, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÁÖ¿ä ±â¾÷Àº Thermo Fisher Scientific Inc., BIOMERIEUX, HiMedia Laboratories, Alifax S.r.l., Creative Diagnostics, Resistell AG, Danaher, BD, Merck KGaA, Bio-Rad Laboratories, Inc., Bruker, ´Ö½ºÀÌ Á¦¾à ÁÖ½Äȸ»ç, Accelerate Diagnostics, Inc., Zhuhai DL Biotech Co.Ltd., ELITechGroup, Sysmex Corporation, Copan Diagnostics Inc., Qualigen Therapeutics, Inc. µîÀÔ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°è Ç×±ÕÁ¦ °¨¼ö¼º Å×½ºÆ® ½ÃÀåÀº ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è Ç×±ÕÁ¦ °¨¼ö¼º Å×½ºÆ® ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀåÀÇ Àü¸Á

  • ¸®Æ÷Æ® ¼³¸í
    • ½ÃÀåÀÇ Á¤ÀÇ¿Í ¹üÀ§
  • °³¿ä
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • ¿µÇ⠺м®
  • ½ÃÀå µ¿Çâ
  • ÁÖ¿ä ¹ßÀü
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Àμö¿Í Á¦ÈÞ ½Ã³ª¸®¿À
  • ÀÚ±ÝÁ¶´Þ°ú ÅõÀÚ
  • PEST ºÐ¼®
  • PorterÀÇ »ê¾÷ ºÐ¼®

Á¦4Àå ¼¼°èÀÇ Ç×±ÕÁ¦ °¨¼ö¼º ½ÃÇè ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ÀüüÀûÀÎ ¿µÇâ
  • Á¤ºÎ ±¸»ó
  • ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ Ç×±ÕÁ¦ °¨¼ö¼º ½ÃÇè ½ÃÀå, Á¦Ç° À¯Çüº°, 2020-2032³â, (10¾ï ´Þ·¯)

  • ¼öµ¿ Ç×±ÕÁ¦ °¨¼ö¼º ½ÃÇè Á¦Ç°
  • °¨¼ö¼º ½ÃÇè µð½ºÅ©
  • ¸¶ÀÌÅ© ½ºÆ®¸³
  • °¨¼ö¼º Ç÷¹ÀÌÆ®
  • ÀÚµ¿È­µÈ ½ÇÇè½Ç ±â±â
  • ¼Ò¸ðǰ

Á¦6Àå ¼¼°èÀÇ Ç×±ÕÁ¦ °¨¼ö¼º ½ÃÇè ½ÃÀå, ¿ëµµº°, 2020-2032³â, (10¾ï ´Þ·¯)

  • Ç×±Õ
  • Ç×Áø±Õ
  • Ç×±â»ýÃæ
  • Ç×¹ÙÀÌ·¯½ºÁ¦

Á¦7Àå ¼¼°èÀÇ Ç×±ÕÁ¦ °¨¼ö¼º ½ÃÇè ½ÃÀå, ¹æ¹ýº°, 2020-2032³â, (10¾ï ´Þ·¯)

  • µð½ºÅ© È®»ê
  • °í¼Ó ÀÚµ¿ AST
  • ºê·Î½º Èñ¼®
  • ±¸¹è È®»ê
  • À¯ÀüÀÚÇü¹ý

Á¦8Àå ¼¼°èÀÇ Ç×±ÕÁ¦ °¨¼ö¼º ½ÃÇè ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2020-2032³â, (10¾ï ´Þ·¯)

  • º´¿ø
  • º´¸®ÇÐ/Áø´Ü °Ë»ç½Ç
  • Á¶»ç¡¤Çмú±â°ü
  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • °è¾à Á¶»ç±â°ü

Á¦9Àå ¼¼°èÀÇ Ç×±ÕÁ¦ °¨¼ö¼º ½ÃÇè ½ÃÀå, Áö¿ªº°, 2020-2032³â, (10¾ï ´Þ·¯)

  • ºÏ¹Ì
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦10Àå °æÀï ±¸µµ

  • ±â¾÷ °³¿ä
    • Thermo Fisher Scientific Inc.
    • BIOMERIEUX
    • HiMedia Laboratories
    • Alifax Srl
    • Creative Diagnostics
    • Resistell AG
    • Danaher
    • BD
    • Merck KGaA
    • Bio-Rad Laboratories, Inc.
    • Bruker
    • Nissui Pharmaceutical Co., Ltd.
    • Accelerate Diagnostics, Inc.
    • Zhuhai DL Biotech Co., Ltd.
    • ELITechGroup
    • Sysmex Corporation
    • Copan Diagnostics Inc.
    • Qualigen Therapeutics, Inc.

Á¦11Àå ¾Ö³Î¸®½ºÆ®ÀÇ ±ÇÀå»çÇ×

  • ¿î¸íÀÇ ¼ö·¹¹ÙÄû
  • ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
  • COM(Coherent Opportunity Map)

Á¦12Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

  • Âü°í ¹®Çå
  • Á¶»ç ¹æ¹ý
KSA 25.04.02

Global Antimicrobial Susceptibility Testing Market is estimated to be valued at USD 4.21 Bn in 2025 and is expected to reach USD 6.72 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 4.21 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.90% 2032 Value Projection: USD 6.72 Bn
Figure. Antimicrobial Susceptibility Testing Market Share (%), By Region 2025
Antimicrobial Susceptibility Testing Market - IMG1

The global antimicrobial susceptibility testing market is projected to witness significant growth from 2025 to 2032. This is mainly due to the rising prevalence of infectious diseases worldwide and increasing need to identify appropriate antibiotic treatments. As per recent studies, at least 2 million people in the U.S. acquire antibiotic-resistant infections every year, leading to over 23,000 deaths. This has boosted the demand for effective antimicrobial susceptibility testing which provides critical information on antibiotic sensitivity that helps clinicians select suitable treatment options. Furthermore, technological advancements in susceptibility testing techniques, such as automation and integration of artificial intelligence, have made the process faster and easier, which is expected to drive the market growth during the forecast period

Market Dynamics:

The global antimicrobial susceptibility testing market is primarily driven by the growing burden of antibiotic-resistant microbial infections and need for rapid and accurate antimicrobial susceptibility testing methods to determine the most effective antimicrobial agents. Some key market drivers include rising prevalence of hospital-acquired infections, increase in new product launches with enhanced capabilities, and initiatives by governments and health agencies to promote antimicrobial stewardship practices. However, the market growth can be challenged by factors such as lengthy approval process for new AST systems, high costs associated with fully-automated systems, and inaccuracies related to manual testing methods. Major opportunities in the market include development of rapid AST platforms with high throughput capabilities, increasing adoption in developing nations, and integration of molecular diagnostic techniques with AST.

Key Features of the Study:

  • This report provides an in-depth analysis of the global antimicrobial susceptibility testing market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global antimicrobial susceptibility testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this includes Thermo Fisher Scientific Inc., BIOMERIEUX, HiMedia Laboratories, Alifax S.r.l., Creative Diagnostics, Resistell AG, Danaher, BD, Merck KGaA, Bio-Rad Laboratories, Inc., Bruker, Nissui Pharmaceutical Co., Ltd., Accelerate Diagnostics, Inc., Zhuhai DL Biotech Co., Ltd., ELITechGroup, Sysmex Corporation, Copan Diagnostics Inc., and Qualigen Therapeutics, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global antimicrobial susceptibility testing market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antimicrobial susceptibility testing market.

Detailed Segmentation-

  • By Product Type:
    • Manual Antimicrobial Susceptibility Testing Products
    • Susceptibility Testing Disks
    • Mic Strips
    • Susceptibility Plates
    • Automated Laboratory Instruments
    • Consumables
  • By Application:
    • Antibacterial
    • Antifungal
    • Anti-parasitic
    • Antiviral
  • By Method:
    • Disk Diffusion
    • Rapid Automated AST
    • Broth Dilution
    • Gradient Diffusion
    • Genotypic Methods
  • By End User:
    • Hospitals
    • Pathology/Diagnostic Laboratories
    • Research and Academic Institutes
    • Pharmaceutical and Biotechnology Companies
    • Contract Research Organizations
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Thermo Fisher Scientific Inc.
    • BIOMERIEUX
    • HiMedia Laboratories
    • Alifax S.r.l.
    • Creative Diagnostics
    • Resistell AG
    • Danaher
    • BD
    • Merck KGaA
    • Bio-Rad Laboratories, Inc.
    • Bruker
    • Nissui Pharmaceutical Co., Ltd.
    • Accelerate Diagnostics, Inc.
    • Zhuhai DL Biotech Co., Ltd.
    • ELITechGroup
    • Sysmex Corporation
    • Copan Diagnostics Inc.
    • Qualigen Therapeutics, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Application
    • Market Snapshot, By Method
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Antimicrobial Susceptibility Testing Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Antimicrobial Susceptibility Testing Market, By Product Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Manual Antimicrobial Susceptibility Testing Products
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Susceptibility Testing Disks
  • Mic Strips
  • Susceptibility Plates
  • Automated Laboratory Instruments
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Consumables
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Antimicrobial Susceptibility Testing Market, By Application, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Antibacterial
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Antifungal
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anti-parasitic
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Antiviral
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Antimicrobial Susceptibility Testing Market, By Method, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Disk Diffusion
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Rapid Automated AST
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Broth Dilution
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Gradient Diffusion
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Genotypic Methods
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Antimicrobial Susceptibility Testing Market, By End User, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pathology/Diagnostic Laboratories
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Research and Academic Institutes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pharmaceutical and Biotechnology Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Contract Research Organizations
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Antimicrobial Susceptibility Testing Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Method, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Method, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Method, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Method, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Method, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Company Profiles
    • Thermo Fisher Scientific Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • BIOMERIEUX
    • HiMedia Laboratories
    • Alifax S.r.l.
    • Creative Diagnostics
    • Resistell AG
    • Danaher
    • BD
    • Merck KGaA
    • Bio-Rad Laboratories, Inc.
    • Bruker
    • Nissui Pharmaceutical Co., Ltd.
    • Accelerate Diagnostics, Inc.
    • Zhuhai DL Biotech Co., Ltd.
    • ELITechGroup
    • Sysmex Corporation
    • Copan Diagnostics Inc.
    • Qualigen Therapeutics, Inc.

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦